Cargando…

Association of Body-Weight Fluctuation With Outcomes in Heart Failure With Preserved Ejection Fraction

Aims: To investigate the relationship between body-weight fluctuation and risks of clinical outcomes in patients with heart failure with preserved ejection fraction (HFpEF). Methods and Results:We measured intra-individual variations in body weight from baseline and follow-up visits in 1,691 partici...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yi, Yu, Yuan, Wu, Yuzhong, Liang, Weihao, Dong, Bin, Xue, Ruicong, Dong, Yugang, Zhu, Wengen, Huang, Peisen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236532/ https://www.ncbi.nlm.nih.gov/pubmed/34195237 http://dx.doi.org/10.3389/fcvm.2021.689591

Ejemplares similares

Weight Change and Mortality Risk in Heart Failure With Preserved Ejection Fraction
por: Huang, Peisen, et al.
Publicado: (2021)

Influence of polypharmacy on patients with heart failure with preserved ejection fraction: a retrospective analysis on adverse outcomes in the TOPCAT trial
por: Wu, Yuzhong, et al.
Publicado: (2020)

C(2)HEST score predicts clinical outcomes in heart failure with preserved ejection fraction: a secondary analysis of the TOPCAT trial
por: Liang, Weihao, et al.
Publicado: (2021)

Clinical implication of pulmonary hospitalization in heart failure with preserved ejection fraction: from the TOPCAT
por: Dong, Bin, et al.
Publicado: (2020)

Mean corpuscular haemoglobin concentration and outcomes in heart failure with preserved ejection fraction
por: Choy, Manting, et al.
Publicado: (2023)

Prognostic significance of resting cardiac power to left ventricular mass and E/e’ ratio in heart failure with preserved ejection fraction
por: Chen, Cong, et al.
Publicado: (2022)

Prognostic Implication of Liver Function Tests in Heart Failure With Preserved Ejection Fraction Without Chronic Hepatic Diseases: Insight From TOPCAT Trial
por: Liang, Weihao, et al.
Publicado: (2021)

Effect of aggressive diuresis in acute heart failure with reduced and preserved ejection fraction
por: He, Xin, et al.
Publicado: (2021)

Clinical Significance of Mean and Pulse Pressure in Patients With Heart Failure With Preserved Ejection Fraction
por: Wei, Fang-Fei, et al.
Publicado: (2021)

Role of Exosomal miRNAs in Heart Failure
por: Xue, Ruicong, et al.
Publicado: (2020)

Usefulness of CHADS2, R2CHADS2, and CHA2DS2‐VASc scores for predicting incident atrial fibrillation in heart failure with preserved ejection fraction patients
por: Wu, Yuzhong, et al.
Publicado: (2021)

Distinct implications of body mass index in different subgroups of nonobese patients with heart failure with preserved ejection fraction: a latent class analysis of data from the TOPCAT trial
por: Dong, Bin, et al.
Publicado: (2022)

Comparison of liver fibrosis scores for predicting mortality and morbidity in heart failure with preserved ejection fraction
por: Cao, Yalin, et al.
Publicado: (2023)

Associations of Left Ventricular Structure and Function With Blood Pressure in Heart Failure With Preserved Ejection Fraction: Analysis of the TOPCAT Trial
por: Wei, Fang‐Fei, et al.
Publicado: (2020)

Sex-Specific Associations of Risks and Cardiac Structure and Function With Microalbumin/Creatinine Ratio in Diastolic Heart Failure
por: Wei, Fang-Fei, et al.
Publicado: (2020)

Phenotypes of heart failure with preserved ejection fraction and effect of spironolactone treatment
por: Choy, Manting, et al.
Publicado: (2022)

Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction
por: Zeng, Heng, et al.
Publicado: (2019)

Interatrial Shunt Device for Heart Failure With Preserved Ejection Fraction
por: Kaye, David M., et al.
Publicado: (2019)

Rationale for the Use of Pirfenidone in Heart Failure With Preserved Ejection Fraction
por: Graziani, Francesca, et al.
Publicado: (2021)

C-reactive protein and statins in heart failure with reduced and preserved ejection fraction
por: Park, Jin Joo, et al.
Publicado: (2022)

Association Between Arterial Stiffness and Heart Failure With Preserved Ejection Fraction
por: Chi, Chen, et al.
Publicado: (2021)

Diving Into the Diagnostic Score Algorithms of Heart Failure With Preserved Ejection Fraction
por: Abramov, Dmitry, et al.
Publicado: (2021)

Heart failure with preserved ejection fraction—Out with the old and out with the new?
por: Tolento Cortes, Luis, et al.
Publicado: (2022)

Skeletal muscle phenotypic switching in heart failure with preserved ejection fraction
por: Saw, Eng Leng, et al.
Publicado: (2022)

Sympathetic and hemodynamic responses to exercise in heart failure with preserved ejection fraction
por: Manabe, Kazumasa, et al.
Publicado: (2023)

Inflammation as a therapeutic target in heart failure with preserved ejection fraction
por: Peh, Zhen Hui, et al.
Publicado: (2023)

Heart failure with preserved ejection fraction: Calculating the risk of future heart failure events and death
por: Schrutka, Lore, et al.
Publicado: (2022)

The Potential Therapeutic Role of Celastrol in Patients With Heart Failure With Preserved Ejection Fraction
por: Ajmal, Maryam, et al.
Publicado: (2021)

Gut Microbiota in Heart Failure Patients With Preserved Ejection Fraction (GUMPTION Study)
por: Huang, Ziyin, et al.
Publicado: (2022)

Advances in Multimodality Cardiovascular Imaging in the Diagnosis of Heart Failure With Preserved Ejection Fraction
por: Del Torto, Alberico, et al.
Publicado: (2022)

Proteomic and phosphoproteomic profiling in heart failure with preserved ejection fraction (HFpEF)
por: Valero-Muñoz, María, et al.
Publicado: (2022)

Lipotoxicity: a driver of heart failure with preserved ejection fraction?
por: Leggat, Jennifer, et al.
Publicado: (2021)

Body Mass Index: An Effective Predictor of Ejection Fraction Improvement in Heart Failure
por: Ye, Li-fang, et al.
Publicado: (2021)

Extracellular vesicles in heart failure – A study in patients with heart failure with preserved ejection fraction or heart failure with reduced ejection fraction characteristics undergoing elective coronary artery bypass grafting
por: Matan, Dmitri, et al.
Publicado: (2022)

Clinical Implications of Plasma Galectin-3 in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis
por: Shi, Yujiao, et al.
Publicado: (2022)

Early Passive Leg Movement Prevents Against the Development of Heart Failure With Preserved Ejection Fraction in Rats
por: Liu, Jian, et al.
Publicado: (2021)

Heart Failure With Preserved Ejection Fraction and Adipose Tissue: A Story of Two Tales
por: Oh, Albin, et al.
Publicado: (2019)

Central and Obstructive Apneas in Heart Failure With Reduced, Mid-Range and Preserved Ejection Fraction
por: Borrelli, Chiara, et al.
Publicado: (2019)

Alteration of m6A RNA Methylation in Heart Failure With Preserved Ejection Fraction
por: Zhang, Beijian, et al.
Publicado: (2021)

Predictive Value of HFA-PEFF Score in Patients With Heart Failure With Preserved Ejection Fraction
por: Sun, Yuxi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_42bo61atoidbm27ru687kjj7v0